To Quiesce or Senesce, That Is the Question for Dedifferentiated Liposarcoma

被引：0
|
作者：
Weiss, Mia C. [1 ,2 ]
Eulo, Vanessa [3 ]
Van Tine, Brian A. [1 ,2 ,4 ,5 ]
机构：
[1] Washington Univ St Louis, Sch Med, Dept Med, Div Med Oncol, St Louis, MO USA
[2] Siteman Canc Ctr, St Louis, MO USA
[3] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
[4] St Louis Childrens Hosp, Dept Pediat Hematol Oncol, St Louis, MO USA
[5] Washington Univ St Louis, Div Med Oncol, Med & Pediat, 660 South Euclid,Campus Box 8007, St Louis, MO 63110 USA
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 04期
关键词：
EFFICACY;
D O I：
10.1158/1078-0432.CCR-23-2787
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Dedifferentiated liposarcoma (DDLPS) has an appealing therapeutic target due to its CDK4 amplification on chromosome 12q. The understanding of geroconversion from quiescent cells to senescent cells defines a patient's response to CDK4 inhibitors. This new observation will inform not only the ongoing phase III clinical trial of abemaciclib, but all future clinical trials in DDLPS. See related article by Gleason et al., p. 703
引用
收藏
页码：649 / 651
页数：3
相关论文
共 50 条
  • [31] Dedifferentiated liposarcoma: Case report
    Mundim, Fiorita G. L.
    Liberato, Wesley R. S.
    Dias, Reigson A.
    Benevenutti, Leticia
    Meira, Felipe R. C.
    Castro, Katia M. T. C.
    Mundim, Pedro G. L.
    Sousa, Nathalia T.
    Reis, Renan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 160 - 161
  • [32] Metabolic vulnerabilities of dedifferentiated liposarcoma
    Brett, Jamie O.
    Han, Ji Seul
    Kim, Choah
    Kelley, Liam P.
    Han, SeongJun
    Boone, Dylan
    Crowley, Joseph
    Joshi, Shakchhi
    Raut, Chandrajit P.
    Greka, Anna
    Haigis, Marcia C.
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Dedifferentiated liposarcoma (DDL) of the extremities
    Barbashina, V
    Singer, S
    Antonescu, CR
    MODERN PATHOLOGY, 2003, 16 (01) : 9A - 9A
  • [34] CASE REPORT: DEDIFFERENTIATED LIPOSARCOMA
    Ofir, Shay Kehat
    Nemet, Arik
    Yassur, Iftah
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 118 - 118
  • [35] α-fetoprotein expression in a dedifferentiated liposarcoma
    Martino Bosco
    Elena Allia
    Jean-Michel Coindre
    Chiara Odasso
    Alberto Pagani
    Donatella Pacchioni
    Virchows Archiv, 2006, 448 : 517 - 520
  • [36] Dedifferentiated Liposarcoma With Myofibroblastic Differentiation
    Wang, Grace Y.
    Lucas, David R.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (10) : 1159 - 1163
  • [37] Retroperitoneal Dedifferentiated Liposarcoma with Infection
    Si, Ying
    Xiao, Ke
    Huang, Yongmao
    SURGICAL INFECTIONS, 2024, 25 (09) : 717 - 718
  • [38] Retroperitoneal Dedifferentiated Liposarcoma: Dedifferentiated Component at the Margin Is Associated with Prognosis
    Dehner, Carina
    Hagemann, Ian
    Chrisinger, John
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 42 - 43
  • [39] Retroperitoneal Dedifferentiated Liposarcoma: Dedifferentiated Component at the Margin Is Associated with Prognosis
    Dehner, Carina
    Hagemann, Ian
    Chrisinger, John
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 42 - 43
  • [40] Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review
    Thway, Khin
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2019, 36 (02) : 112 - 121
12345